High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trial

Orly Vardeny, Jacob A. Udell, Jacob Joseph, Michael E. Farkouh, Adrian F. Hernandez, Alison J. McGeer, H. Keipp Talbot, Deepak L. Bhatt, Christopher P. Cannon, Shaun G. Goodman, Inder Anand, David L. DeMets, Jon Temte, Janet Wittes, Kristin Nichol, Clyde W. Yancy, J. Michael Gaziano, Lawton S. Cooper, Kyung Mann Kim, Scott D. Solomon

Research output: Contribution to journal › Article › peer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trial'. Together they form a unique fingerprint.

Medicine & Life Sciences